← Back to headlines

Eli Lilly to acquire Seattle-area biotech in $1.5 billion bet on next-generation shingles vaccine

This story is reported by GeekWire. Read what other outlets are saying below, then open the original report for full details.

Eli Lilly to acquire Seattle-area biotech in $1.5 billion bet on next-generation shingles vaccine · NabkaNews